SEMA-10 — Semaglutide
Semaglutide is a GLP-1 receptor agonist studied in metabolic and endocrine research.
Binds GLP-1 receptors in the pancreas (glucose-dependent insulin secretion, glucagon suppression), hypothalamus (satiety via POMC/CART neuron activation), gut (delayed gastric emptying reducing post-meal glucose spikes), and brainstem (appetite suppression). The C18 fatty acid linker enables 7-day half-life via albumin binding.
⚠️ FOR RESEARCH ONLY!
Disclaimer
For research purposes only. Not for human or animal use and not FDA-approved. By purchasing, you confirm that you are 21 years of age or older and are a qualified researcher.
Safety and Compliance Statement
This material is intended solely for research purposes under the guidance of qualified professionals. GHK-CU is not approved for human or animal consumption and should be handled with appropriate caution, following established laboratory protocols. Users are advised to conduct experiments in compliance with institutional regulations and safety standards.
For research use only. Not for human or animal consumption.
